Caffeine in the Second Stage: A Randomized Control Trial in Low-risk Nulliparous Mothers at Term

• Status: Not yet recruiting
• Trial end date: 2024-08-01
• Target enrollment: 0
• Participant gender: Female

Summary

Double blind, randomized control trial to determine benefit of caffeine and sodium benzoate on the second stage of labor

• Phase: Phase 1
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: The Reading Hospital and Medical Center
• Treatments: Caffeine; Caffeine, sodium benzoate drug combination; Sodium Benzoate

Criteria

Inclusion Criteria:

• Nulliparous pregnant mothers at term (37 weeks gestation and above), intravenous access.

Exclusion Criteria:

• Hypertensive disorders (chronic hypertension, gestation hypertension, pre-eclampsia, HELLP syndrome), significant cardiac history (history of myocardial infarction, stroke, arrhythmias, cardiomyopathy), positive drug screen on admission for cocaine or amphetamines, fetal malpresentation